List of Tables
Table 1. Global Nonnarcotic Analgesics Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Nonnarcotic Analgesics Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Nonnarcotic Analgesics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Nonnarcotic Analgesics Market Competitive Situation by Manufacturers in 2021
Table 5. Global Nonnarcotic Analgesics Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Nonnarcotic Analgesics Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Nonnarcotic Analgesics Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Nonnarcotic Analgesics Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Nonnarcotic Analgesics Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Nonnarcotic Analgesics Manufacturing Sites and Area Served
Table 11. Manufacturers Nonnarcotic Analgesics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nonnarcotic Analgesics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonnarcotic Analgesics as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nonnarcotic Analgesics Sales by Region (2017-2022) & (K Units)
Table 16. Global Nonnarcotic Analgesics Sales Market Share by Region (2017-2022)
Table 17. Global Nonnarcotic Analgesics Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Nonnarcotic Analgesics Revenue Market Share by Region (2017-2022)
Table 19. North America Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 20. North America Nonnarcotic Analgesics Sales Market Share by Country (2017-2022)
Table 21. North America Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Nonnarcotic Analgesics Revenue Market Share by Country (2017-2022)
Table 23. Europe Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 24. Europe Nonnarcotic Analgesics Sales Market Share by Country (2017-2022)
Table 25. Europe Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Nonnarcotic Analgesics Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Nonnarcotic Analgesics Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Nonnarcotic Analgesics Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Nonnarcotic Analgesics Revenue Market Share by Region (2017-2022)
Table 31. Latin America Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Nonnarcotic Analgesics Sales Market Share by Country (2017-2022)
Table 33. Latin America Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Nonnarcotic Analgesics Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Nonnarcotic Analgesics Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Nonnarcotic Analgesics Revenue Market Share by Country (2017-2022)
Table 39. Global Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 40. Global Nonnarcotic Analgesics Sales Market Share by Type (2017-2022)
Table 41. Global Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Nonnarcotic Analgesics Revenue Share by Type (2017-2022)
Table 43. Global Nonnarcotic Analgesics Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Nonnarcotic Analgesics Sales (K Units) by Application (2017-2022)
Table 45. Global Nonnarcotic Analgesics Sales Market Share by Application (2017-2022)
Table 46. Global Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Nonnarcotic Analgesics Revenue Share by Application (2017-2022)
Table 48. Global Nonnarcotic Analgesics Price by Application (2017-2022) & (US$/Unit)
Table 49. GlaxoSmithKline Consumer Healthcare Corporation Information
Table 50. GlaxoSmithKline Consumer Healthcare Description and Business Overview
Table 51. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product
Table 53. GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
Table 54. Bayer Corporation Corporation Information
Table 55. Bayer Corporation Description and Business Overview
Table 56. Bayer Corporation Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Bayer Corporation Nonnarcotic Analgesics Product
Table 58. Bayer Corporation Recent Developments/Updates
Table 59. Atnahs Pharma Corporation Information
Table 60. Atnahs Pharma Description and Business Overview
Table 61. Atnahs Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Atnahs Pharma Nonnarcotic Analgesics Product
Table 63. Atnahs Pharma Recent Developments/Updates
Table 64. Baudax Bio Corporation Information
Table 65. Baudax Bio Description and Business Overview
Table 66. Baudax Bio Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Baudax Bio Nonnarcotic Analgesics Product
Table 68. Baudax Bio Recent Developments/Updates
Table 69. Prestige Brands, Inc. Corporation Information
Table 70. Prestige Brands, Inc. Description and Business Overview
Table 71. Prestige Brands, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Prestige Brands, Inc. Nonnarcotic Analgesics Product
Table 73. Prestige Brands, Inc. Recent Developments/Updates
Table 74. Cumberland Pharmaceuticals, Inc. Corporation Information
Table 75. Cumberland Pharmaceuticals, Inc. Description and Business Overview
Table 76. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 78. Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
Table 79. Takeda Pharmaceutical Company Corporation Information
Table 80. Takeda Pharmaceutical Company Description and Business Overview
Table 81. Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product
Table 83. Takeda Pharmaceutical Company Recent Developments/Updates
Table 84. Pfizer Inc. Corporation Information
Table 85. Pfizer Inc. Description and Business Overview
Table 86. Pfizer Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Pfizer Inc. Nonnarcotic Analgesics Product
Table 88. Pfizer Inc. Recent Developments/Updates
Table 89. McNeil Consumer Healthcare Corporation Information
Table 90. McNeil Consumer Healthcare Description and Business Overview
Table 91. McNeil Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. McNeil Consumer Healthcare Nonnarcotic Analgesics Product
Table 93. McNeil Consumer Healthcare Recent Developments/Updates
Table 94. Eli Lilly and Company Corporation Information
Table 95. Eli Lilly and Company Description and Business Overview
Table 96. Eli Lilly and Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Eli Lilly and Company Nonnarcotic Analgesics Product
Table 98. Eli Lilly and Company Recent Developments/Updates
Table 99. Sun Pharmaceutical Industries Corporation Information
Table 100. Sun Pharmaceutical Industries Description and Business Overview
Table 101. Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product
Table 103. Sun Pharmaceutical Industries Recent Developments/Updates
Table 104. Validus Pharmaceuticals Corporation Information
Table 105. Validus Pharmaceuticals Description and Business Overview
Table 106. Validus Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Validus Pharmaceuticals Nonnarcotic Analgesics Product
Table 108. Validus Pharmaceuticals Recent Developments/Updates
Table 109. Novartis Consumer Health Corporation Information
Table 110. Novartis Consumer Health Description and Business Overview
Table 111. Novartis Consumer Health Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Novartis Consumer Health Nonnarcotic Analgesics Product
Table 113. Novartis Consumer Health Recent Developments/Updates
Table 114. Pacira Pharmaceuticals, Inc. Corporation Information
Table 115. Pacira Pharmaceuticals, Inc. Description and Business Overview
Table 116. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 118. Pacira Pharmaceuticals, Inc. Recent Developments/Updates
Table 119. Almatica Pharma Corporation Information
Table 120. Almatica Pharma Description and Business Overview
Table 121. Almatica Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Almatica Pharma Nonnarcotic Analgesics Product
Table 123. Almatica Pharma Recent Developments/Updates
Table 124. Actavis Corporation Information
Table 125. Actavis Description and Business Overview
Table 126. Actavis Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Actavis Nonnarcotic Analgesics Product
Table 128. Actavis Recent Developments/Updates
Table 129. Arbor Pharmaceuticals, LLC Corporation Information
Table 130. Arbor Pharmaceuticals, LLC Description and Business Overview
Table 131. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product
Table 133. Arbor Pharmaceuticals, LLC Recent Developments/Updates
Table 134. PLx Pharma Inc. Corporation Information
Table 135. PLx Pharma Inc. Description and Business Overview
Table 136. PLx Pharma Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. PLx Pharma Inc. Nonnarcotic Analgesics Product
Table 138. PLx Pharma Inc. Recent Developments/Updates
Table 139. Heron Therapeutics Corporation Information
Table 140. Heron Therapeutics Description and Business Overview
Table 141. Heron Therapeutics Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Heron Therapeutics Nonnarcotic Analgesics Product
Table 143. Heron Therapeutics Recent Developments/Updates
Table 144. Assertio Therapeutics, Inc. Corporation Information
Table 145. Assertio Therapeutics, Inc. Description and Business Overview
Table 146. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product
Table 148. Assertio Therapeutics, Inc. Recent Developments/Updates
Table 149. Zyla Life Sciences Corporation Information
Table 150. Zyla Life Sciences Description and Business Overview
Table 151. Zyla Life Sciences Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Zyla Life Sciences Nonnarcotic Analgesics Product
Table 153. Zyla Life Sciences Recent Developments/Updates
Table 154. Jazz Pharmaceuticals plc Corporation Information
Table 155. Jazz Pharmaceuticals plc Description and Business Overview
Table 156. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product
Table 158. Jazz Pharmaceuticals plc Recent Developments/Updates
Table 159. Production Base and Market Concentration Rate of Raw Material
Table 160. Key Suppliers of Raw Materials
Table 161. Nonnarcotic Analgesics Distributors List
Table 162. Nonnarcotic Analgesics Customers List
Table 163. Nonnarcotic Analgesics Market Trends
Table 164. Nonnarcotic Analgesics Market Drivers
Table 165. Nonnarcotic Analgesics Market Challenges
Table 166. Nonnarcotic Analgesics Market Restraints
Table 167. Global Nonnarcotic Analgesics Sales Forecast by Type (2023-2028) & (K Units)
Table 168. Global Nonnarcotic Analgesics Sales Market Share Forecast by Type (2023-2028)
Table 169. Global Nonnarcotic Analgesics Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 170. Global Nonnarcotic Analgesics Revenue Market Share Forecast by Type (2023-2028)
Table 171. Global Nonnarcotic Analgesics Sales Forecast by Application (2023-2028) & (K Units)
Table 172. Global Nonnarcotic Analgesics Sales Market Share Forecast by Application (2023-2028)
Table 173. Global Nonnarcotic Analgesics Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 174. Global Nonnarcotic Analgesics Revenue Market Share Forecast by Application (2023-2028)
Table 175. Global Nonnarcotic Analgesics Sales Forecast by Region (2023-2028) & (K Units)
Table 176. Global Nonnarcotic Analgesics Sales Market Share Forecast by Region (2023-2028)
Table 177. Global Nonnarcotic Analgesics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 178. Global Nonnarcotic Analgesics Revenue Market Share Forecast by Region (2023-2028)
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nonnarcotic Analgesics
Figure 2. Global Nonnarcotic Analgesics Market Share by Type in 2021 & 2028
Figure 3. Salicylates Product Picture
Figure 4. Anilines Product Picture
Figure 5. Pyrazolones Product Picture
Figure 6. Other Organic Acids Product Picture
Figure 7. Global Nonnarcotic Analgesics Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Specialist Clinic
Figure 11. Other
Figure 12. Global Nonnarcotic Analgesics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Nonnarcotic Analgesics Market Size (2017-2028) & (US$ Million)
Figure 14. Global Nonnarcotic Analgesics Sales (2017-2028) & (K Units)
Figure 15. Nonnarcotic Analgesics Sales Share by Manufacturers in 2021
Figure 16. Global Nonnarcotic Analgesics Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Nonnarcotic Analgesics Players: Market Share by Revenue in 2021
Figure 18. Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Nonnarcotic Analgesics Sales Market Share by Region (2017-2022)
Figure 20. Global Nonnarcotic Analgesics Sales Market Share by Region in 2021
Figure 21. Global Nonnarcotic Analgesics Revenue Market Share by Region (2017-2022)
Figure 22. Global Nonnarcotic Analgesics Revenue Market Share by Region in 2021
Figure 23. United States Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. China Taiwan Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Colombia Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Nonnarcotic Analgesics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Nonnarcotic Analgesics by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Nonnarcotic Analgesics
Figure 48. Manufacturing Process Analysis of Nonnarcotic Analgesics
Figure 49. Nonnarcotic Analgesics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
